Category Archives: Myocardial Infarction

Editor's note: Some details have been changed to protect the patient's identity. Jaya Mallidi, MD, MHS It was an unusually quiet Saturday afternoon on call. I was sipping coffee and leisurely reading that day's echocardiograms. Continue reading →

OFALLON - HSHS St. Elizabeths has received the American College of Cardiologys NCDR Chest Pain - MI Registry Platinum Performance Achievement Award for 2020. St. Continue reading →

TEL AVIV, Israel, Sept. 03, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announces the award for Best ESC Congress Poster for the presentation of updated data from the large, long-term PARADIGM-EXTEND study of the CGuard Embolic Prevention System (EPS), as part of the European Society of Cardiology 2020 Carotid Update e-presentation at the European Society of Cardiology (ESC) Congress 2020. Continue reading →

Long Hu,1 Wei Lin,2 Tiancheng Xu,1 Dongjie Liang,1 Guangze Xiang,1 Rujie Zheng,1 Changzuan Zhou,1 Qinxue Dai,3 Danyun Jia3 1Department of Cardiovascular Medicine, The Heart Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang, Peoples Republic of China; 2Department of Pediatric Intensive Care Unit, The Second Affiliated Hospital and Yuying Childrens Hospital of Wenzhou Medical University, Wenzhou 325027, Zhejiang, Peoples Republic of China; 3Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang, Peoples Republic of China Correspondence: Danyun Jia; Qinxue Dai Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Nanbaixiang, Ouhai District, Wenzhou City 325000, Zhejiang Province, Peoples Republic of China Tel/Fax +86-577-88581162 Email 529365150@qq.com; 653091408@qq.com Background: Admission lactate level has been reported as a useful marker of mortality. In this study, we compared the relative value of different lactate indices to predict survival in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Methods: This was a retrospective observational study including consecutive patients with STEMI undergoing primary PCI who admitted to the Coronary Care Unit of the First Affiliated Hospital of Wenzhou Medical University between 2014 and 2017. Continue reading →

CAMBRIDGE, Mass., Sept. Continue reading →

MONTREAL, Aug. 31, 2020 /PRNewswire/ - The Montreal Heart Institute (MHI) released earlier today two more research publications confirming the benefits of low dose (0,5mg daily) colchicine in preventing the risks of ischemic cardiovascular events in patients having undergone myocardial infarction (MI). Continue reading →

This article was originally published here ACR Open Rheumatol. 2020 Sep 1 Continue reading →

Microorganisms in the human digestive tract are linked to 29 specific health conditions, including chronic obstructive pulmonary disease, high blood pressure, and type 2 diabetes, according to a genome analysis in more than 400,000 individuals. Although previous studies have suggested a link between gut microbiota and diseases in humans, "the extent to which the human gut microbiome can be considered a determinant of disease and healthy aging remains unknown," Hilde E. Groot, MD, of the University of Groningen (The Netherlands), said in a presentation at the virtual annual congress of the European Society of Cardiology. Continue reading →

Background/objectives:Older patients are underrepresented in acute coronary syndrome clinical trials. We sought to evaluate the benefits of revascularization in patients aged 80 years and older presenting with acute myocardial infarction (AMI) Continue reading →

Contrive Datum Insights has newly published statistical data on Myocardial Infarction Treatment market. It gives an analytical view of various industries which gives a basic understanding of all the business scenarios. Through qualitative and quantitative research, it gives an optimal solution for the development of the Myocardial Infarction Treatment industries Continue reading →